Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 87901-87950 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05332769
Cumulus Cell Mitochondrial Activity as a Non-invasive Marker of Embryo Quality (FLIM)
N/AActive, not recruiting
200 participants
Started: Apr 25, 2022 · Completed: Dec 30, 2026
4 conditions4 sponsors1 location
NCT05347732
Predictors of Failed Thrombolysis in Acute Myocardial Infarction
N/ARecruiting
200 participants
Started: Apr 25, 2022 · Completed: Jan 3, 2035
1 condition1 sponsor1 location
NCT05101746
Nitric Oxide Effect on Brain and Kidney in Pediatric Patients Undergoing Cardiopulmonary Bypass
PHASE2/PHASE3Enrolling by invitation
50 participants
Started: Apr 25, 2022 · Completed: Sep 30, 2026
3 conditions1 sponsor1 location
NCT06683248
The Effects of Night Shift Work on Health Across the Menstrual Cycle
NARecruiting
60 participants
Started: Apr 25, 2022 · Completed: Dec 31, 2025
6 conditions1 sponsor1 location
NCT05263310
Prepare for Your Diabetes Care
NAActive, not recruiting
600 participants
Started: Apr 25, 2022 · Completed: Mar 30, 2026
3 conditions2 sponsors1 location
NCT05289739
Exercise Training in Childhood Cancer
NAActive, not recruiting
450 participants
Started: Apr 25, 2022 · Completed: Aug 31, 2026
1 condition11 sponsors1 location
NCT05528783
Application of FIT-DNA Detection in Following Colorectal Cancer Resection-Implications for Surveillance
N/ARecruiting
200 participants
Started: Apr 25, 2022 · Completed: Jan 31, 2027
1 condition2 sponsors1 location
NCT05358717
A Study to Evaluate the Safety and Efficacy of PTC518 in Participants With Huntington's Disease (HD)
PHASE2Active, not recruiting
252 participants
Started: Apr 25, 2022 · Completed: Aug 15, 2025
1 condition1 sponsor28 locations
NCT05320354
Diagnosis and Bacterial Identification of Periprosthetic Joint Infection With Microbial-ID
N/AEnrolling by invitation
200 participants
Started: Apr 25, 2022 · Completed: Dec 1, 2025
2 conditions2 sponsors6 locations
NCT04931797
Video Images About Decisions for Ethical Outcomes in the Emergency Department (VIDEO-ED)
NARecruiting
900 participants
Started: Apr 25, 2022 · Completed: Jun 30, 2025
1 condition3 sponsors4 locations
NCT05057858
The Women TDF-FTC Benchmark Study
PHASE2Active, not recruiting
72 participants
Started: Apr 25, 2022 · Completed: Jan 31, 2025
1 condition4 sponsors1 location
NCT06036342
Atrial Fibrillation Screening With MobiCARE in Subjects With Health Care Examination
N/AActive, not recruiting
3,000 participants
Started: Apr 25, 2022 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT04888936
Clinical, Genetic, and Epidemiologic Study of Children and Adults With RASopathies
N/ARecruiting
500 participants
Started: Apr 25, 2022 · Completed: Jan 31, 2035
6 conditions1 sponsor2 locations
NCT05178693
Lutathera and ASTX727 in Neuroendocrine Tumours
PHASE1Recruiting
27 participants
Started: Apr 25, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05127109
The PASTDUe Nutrition Ecosystem Project (PASTDUe)
PHASE4Recruiting
300 participants
Started: Apr 25, 2022 · Completed: Jan 1, 2026
13 conditions1 sponsor1 location
NCT05266092
Activation of the Contact System and the Immune System in Patients With Chronic Kidney Disease.
N/ARecruiting
400 participants
Started: Apr 25, 2022 · Completed: Apr 30, 2032
1 condition2 sponsors1 location
NCT04014140
iFR Guided Coronary Artery Bypass Grafting Surgery
N/ARecruiting
100 participants
Started: Apr 25, 2022 · Completed: Aug 31, 2026
3 conditions1 sponsor1 location
NCT05335590
Adherence and Clinical Correlates in Persons With HIV on TAF
N/AActive, not recruiting
384 participants
Started: Apr 25, 2022 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT05171647
A Study Evaluating Efficacy and Safety of Mosunetuzumab in Combination With Polatuzumab Vedotin Compared to Rituximab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed or Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma
PHASE3Active, not recruiting
242 participants
Started: Apr 25, 2022 · Completed: Feb 28, 2027
1 condition1 sponsor52 locations
NCT05330442
Building Experience for Treating Trauma and Enhancing Resilience (BETTER)
NAActive, not recruiting
720 participants
Started: Apr 25, 2022 · Completed: Jun 30, 2026
1 condition3 sponsors10 locations
NCT05346224
A Study to Evaluate the Efficacy and Safety of HLX11 vs. EU-Perjeta® in the Neoadjuvant Therapy of HER2-Positive and HR-Negative Early-stage or Locally Advanced Breast Cancer
PHASE3Active, not recruiting
900 participants
Started: Apr 25, 2022 · Completed: Dec 30, 2025
3 conditions1 sponsor79 locations
NCT05237934
Tissue Procurement and Natural History Study of Neuroendocrine Neoplasms (NENs) Including Adrenocortical Carcinoma (ACC)
N/ARecruiting
300 participants
Started: Apr 25, 2022 · Completed: Dec 31, 2032
2 conditions1 sponsor1 location
NCT05710549
Understanding Brain Mechanisms Involved in Autobiographical Memory
NARecruiting
120 participants
Started: Apr 25, 2022 · Completed: Aug 1, 2027
3 conditions1 sponsor1 location
NCT05331378
Clinical Evaluation of a Myopia Control Lens in Slowing Myopia Progression
NAActive, not recruiting
80 participants
Started: Apr 25, 2022 · Completed: Oct 31, 2025
2 conditions1 sponsor1 location
NCT05141890
Probiotics for Inflammation in Pediatric Chronic Pain
NAActive, not recruiting
39 participants
Started: Apr 25, 2022 · Completed: Dec 1, 2025
2 conditions1 sponsor1 location
NCT05182164
Combination of Pembrolizumab and Cabozantinib in Patients With Advanced Sarcomas
PHASE2Recruiting
119 participants
Started: Apr 25, 2022 · Completed: Dec 31, 2027
5 conditions3 sponsors10 locations
NCT05345431
Endovascular Denervation for the Treatment of Patients With Peripheral Arterial Disease
NARecruiting
54 participants
Started: Apr 25, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05409300
Evaluation of the Immunogenicity and Safety BBIBP-CorV Vaccine for COVID-19 in Adults in Guinea
PHASE2Active, not recruiting
200 participants
Started: Apr 25, 2022 · Completed: Feb 28, 2025
4 conditions8 sponsors2 locations
NCT05354622
Hereditary Spastic Paraplegia Genomic Sequencing Initiative (HSPseq)
N/ARecruiting
200 participants
Started: Apr 25, 2022 · Completed: Apr 29, 2027
6 conditions2 sponsors1 location
NCT05593237
Transcranial Magnetic Stimulation for Chronic Neuropathic Pain
NARecruiting
32 participants
Started: Apr 25, 2022 · Completed: Jan 30, 2026
9 conditions1 sponsor1 location
NCT05344235
Observational Study on Extreme Hypofractionation for Localized Prostate Cancer
N/ARecruiting
246 participants
Started: Apr 25, 2022 · Completed: Apr 30, 2032
3 conditions1 sponsor1 location
NCT05053555
High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies
NARecruiting
60 participants
Started: Apr 24, 2022 · Completed: Jan 31, 2027
4 conditions1 sponsor1 location
NCT05319574
SBRT Followed by Neoadjuvant Immunochemotherapy in Resectable Stage II to III Non-small Cell Lung Cancer
PHASE2Active, not recruiting
46 participants
Started: Apr 24, 2022 · Completed: May 31, 2026
1 condition1 sponsor1 location
NCT05444452
GENOSS Coronary Stent Clinical Trial
NARecruiting
850 participants
Started: Apr 24, 2022 · Completed: Jun 30, 2027
1 condition2 sponsors1 location
NCT06781450
Study in Patients With Relapsed/Refractory Primary Mediastinal Lymphoma Treated With Pembrolizumab or Nivolumab in Combination With Brentuximab Vedotin in a Real-life Context
N/ARecruiting
50 participants
Started: Apr 23, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor3 locations
NCT05136339
Healthy Immigrant Community: Mobilizing the Power of Social Networks
NAActive, not recruiting
481 participants
Started: Apr 23, 2022 · Completed: Jun 30, 2025
1 condition2 sponsors1 location
NCT05807672
Magnetic Resonance Fingerprinting in the Imaging of Endometrial Cancer
N/ARecruiting
150 participants
Started: Apr 23, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05658068
Systems Aligning for Equity (SAFE) Spaces
NARecruiting
800 participants
Started: Apr 23, 2022 · Completed: May 31, 2025
5 conditions1 sponsor1 location
NCT05281016
Integrating Community LITE Programme as an Online Family-based Intervention to Combat Childhood Obesity
NARecruiting
100 participants
Started: Apr 22, 2022 · Completed: Dec 31, 2025
1 condition5 sponsors1 location
NCT05143840
Asciminib as Initial Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase
PHASE2Recruiting
100 participants
Started: Apr 22, 2022 · Completed: Feb 29, 2032
4 conditions2 sponsors6 locations
NCT05393609
Quality of Life and Surgery in Diverticular Disease
N/ARecruiting
250 participants
Started: Apr 22, 2022 · Completed: Mar 31, 2025
3 conditions2 sponsors1 location
NCT05341453
Hippotherapy in Children With Spinal Muscular Atrophy
NARecruiting
16 participants
Started: Apr 22, 2022 · Completed: Oct 22, 2025
1 condition1 sponsor1 location
NCT04843865
TCM as an Adjuvant Treatment in Breast Cancer Patients
NARecruiting
30 participants
Started: Apr 22, 2022 · Completed: Dec 31, 2024
2 conditions1 sponsor1 location
NCT05277935
Wearable Enhanced Fitness Tracking for Metastatic Breast Cancer Patients Using Endocrine Treatment and Palbociclib
NARecruiting
68 participants
Started: Apr 22, 2022 · Completed: Mar 1, 2025
2 conditions1 sponsor4 locations
NCT05864105
PM8002 in Combination With Chemotherapy as First Line Therapy in Hepatocellular Carcinoma
PHASE2Active, not recruiting
35 participants
Started: Apr 22, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor9 locations
NCT05315752
Changes in Body Fat and Morphologic Characteristics Associated With OSA Resolution After Bariatric Surgery
N/ARecruiting
60 participants
Started: Apr 22, 2022 · Completed: Dec 31, 2026
2 conditions1 sponsor2 locations
NCT05360732
Redefining FOLFIORINOX in Older Pancreatic Cancer Patients
PHASE2Recruiting
37 participants
Started: Apr 22, 2022 · Completed: Sep 1, 2025
1 condition1 sponsor1 location
NCT05590637
Comparing Antipsychotic Medications in LBD Over Time
PHASE4Recruiting
94 participants
Started: Apr 22, 2022 · Completed: Feb 28, 2027
2 conditions2 sponsors2 locations
NCT05575440
Evaluation of 18F-TFB PET/CT Scan in Patients With Differentiated Thyroid Cancer
N/ARecruiting
24 participants
Started: Apr 22, 2022 · Completed: May 1, 2028
3 conditions1 sponsor1 location
NCT05120492
Optimal Management of Extreme Obesity and Severe Knee Osteoarthritis Feasibility Trial
NARecruiting
20 participants
Started: Apr 22, 2022 · Completed: Jul 31, 2027
2 conditions1 sponsor1 location